Chemistry: molecular biology and microbiology – Vector – per se
Reexamination Certificate
2007-12-06
2010-06-08
Wehbe, Anne Marie S (Department: 1633)
Chemistry: molecular biology and microbiology
Vector, per se
C536S023500
Reexamination Certificate
active
07732196
ABSTRACT:
Disclosed herein are methods and compositions for treatment of conditions requiring inhibition of angiogenesis. Such conditions include those characterized by neovascularization, such as retinopathies, macular degeneration and various malignancies.
REFERENCES:
patent: 4186183 (1980-01-01), Steck et al.
patent: 4217344 (1980-08-01), Vanlerberghe et al.
patent: 4235871 (1980-11-01), Papahadjopoulos et al.
patent: 4261975 (1981-04-01), Fullerton et al.
patent: 4485054 (1984-11-01), Mezei et al.
patent: 4501728 (1985-02-01), Geho et al.
patent: 4603044 (1986-07-01), Geho et al.
patent: 4774085 (1988-09-01), Fidler
patent: 4797368 (1989-01-01), Carter et al.
patent: 4837028 (1989-06-01), Allen
patent: 4897355 (1990-01-01), Eppstein et al.
patent: 4946787 (1990-08-01), Eppstein et al.
patent: 4957773 (1990-09-01), Spencer et al.
patent: 5049386 (1991-09-01), Eppstein et al.
patent: 5173414 (1992-12-01), Lebkowski et al.
patent: 5176996 (1993-01-01), Hogan et al.
patent: 5210015 (1993-05-01), Gelfand et al.
patent: 5422251 (1995-06-01), Fresco
patent: 5538848 (1996-07-01), Livak et al.
patent: 5585245 (1996-12-01), Johnsson et al.
patent: 5607918 (1997-03-01), Eriksson et al.
patent: 5776755 (1998-07-01), Alitalo et al.
patent: 5789538 (1998-08-01), Rebar et al.
patent: 5840686 (1998-11-01), Chader et al.
patent: 5840693 (1998-11-01), Eriksson et al.
patent: 5863736 (1999-01-01), Haaland
patent: 5928939 (1999-07-01), Eriksson et al.
patent: 5932540 (1999-08-01), Hu et al.
patent: 5935820 (1999-08-01), Hu et al.
patent: 5994300 (1999-11-01), Bayne et al.
patent: 6007988 (1999-12-01), Choo et al.
patent: 6013453 (2000-01-01), Choo et al.
patent: 6040157 (2000-03-01), Hu et al.
patent: 6130071 (2000-10-01), Alitalo et al.
patent: 6140081 (2000-10-01), Barbas
patent: 6140466 (2000-10-01), Barbas et al.
patent: 6242568 (2001-06-01), Barbas et al.
patent: 6288024 (2001-09-01), Bouck et al.
patent: 6319687 (2001-11-01), Chader et al.
patent: 6391850 (2002-05-01), Bouck et al.
patent: 6410248 (2002-06-01), Greisman et al.
patent: 6451763 (2002-09-01), Tombran-Tink et al.
patent: 6453242 (2002-09-01), Eisenberg et al.
patent: 6479626 (2002-11-01), Kim et al.
patent: 6534261 (2003-03-01), Cox et al.
patent: 6573092 (2003-06-01), Kovesdi et al.
patent: 6607882 (2003-08-01), Cox et al.
patent: 6670333 (2003-12-01), Bouck et al.
patent: 6746838 (2004-06-01), Choo et al.
patent: 6785613 (2004-08-01), Eisenberg et al.
patent: 6790941 (2004-09-01), Barbas, III et al.
patent: 6794136 (2004-09-01), Eisenberg et al.
patent: 6797691 (2004-09-01), Bouck et al.
patent: 6824978 (2004-11-01), Cox, III et al.
patent: 2002/0064802 (2002-05-01), Raschke et al.
patent: 2003/0119023 (2003-06-01), Choo et al.
patent: 0 476 983 (1992-03-01), None
patent: WO 91/16024 (1991-10-01), None
patent: WO 91/17424 (1991-11-01), None
patent: WO 93/24641 (1993-02-01), None
patent: WO 95/19431 (1995-07-01), None
patent: WO 95/24473 (1995-09-01), None
patent: WO 96/06166 (1996-02-01), None
patent: WO 96/26736 (1996-09-01), None
patent: WO 96/27007 (1996-09-01), None
patent: WO 96/39515 (1996-12-01), None
patent: WO 97/05250 (1997-02-01), None
patent: WO 97/09427 (1997-03-01), None
patent: WO 97/17442 (1997-05-01), None
patent: WO 98/07832 (1998-02-01), None
patent: WO 98/33917 (1998-02-01), None
patent: WO 98/24811 (1998-06-01), None
patent: WO 98/44350 (1998-10-01), None
patent: WO 98/53057 (1998-11-01), None
patent: WO 98/53058 (1998-11-01), None
patent: WO 98/53059 (1998-11-01), None
patent: WO 98/53060 (1998-11-01), None
patent: WO 98/54311 (1998-12-01), None
patent: WO 99/33485 (1999-07-01), None
patent: WO 99/46364 (1999-09-01), None
patent: WO 00/09148 (2000-02-01), None
patent: WO 00/23464 (2000-04-01), None
patent: WO 00/27878 (2000-05-01), None
patent: WO 00/41566 (2000-07-01), None
patent: WO 00/42219 (2000-07-01), None
patent: WO 00/45835 (2000-08-01), None
patent: WO 01/83732 (2001-11-01), None
patent: WO 01/83793 (2001-11-01), None
patent: WO 02/46412 (2002-06-01), None
patent: WO 02/077227 (2002-10-01), None
patent: WO 03/080648 (2003-10-01), None
patent: WO/2004/108883 (2004-12-01), None
patent: WO 2004/108883 (2004-12-01), None
Rainov et al. (2001) Current Gene Therapy, vol. 1, 367-383.
Greisman et al. (1997) Science, vol. 275, 657-661.
Tan et al. (2003) PNAS, vol. 100(21), 11997-12002.
Abe, et al., “Overexpression of Pigment Epithelium-Derived Factor Decreases Angiogenesis and Inhibits the Growth of Human Malignant Melanoma Cells in Vivo,”Am J Pathol 164:1225-1232 (2004).
Ahmad, et al., “Antibody-Mediated Specific Binding and Cytotoxicity of Liposome-Entrapped Doxorubicin to Lung Cancer Cells in Vitro,”Cancer Res 52(17):4817-4820 (1992).
Altschul, et al., “Basic Local Alignment Search Tool,”J. Mol. Biol. 215:403-410 (1990).
Alvarez et al. “A Phase I Study of Recombinant Adenovirus Vector-Mediated Intraperitoneal Delivery of Herpes Simplex Virus Thymidine Kinase (HSV-TK) Gene and Intravenous Ganciclovir for Previously Treated Ovarian and Extraovarian Cancer Patients,”Hum. Gene Ther. 8(5):597-613 (1997).
Beaucage et al., “Deoxynucleoside Phosphoramidites—A New Class of Key Intermediates for Deoxypolynucleotides,”Tetrahedron Letters 22:1859-1862 (1981).
Behr et al., “Gene Transfer With Synthetic Cationic Amphiphiles: Prospects for Gene Therapy,”Bioconjug. Chem. 5(5):382-389 (1994).
Berg and Shi, “The Galvanization of Biology: A Growing Appreciation for the Roles of Zinc,”Science 271:1081-1085 (1996).
Bird et al., “Methylation-Induced Repression—Belts, Braces, and Chromatin,”Cell 99(5):451-454 (1999).
Bitko & Barik, “Persistent Activation of Rela by Respiratory Syncytial Virus Involves Protein Kinase C, Underphosphorylated Ikappabbeta, and Sequestration of Protein Phosphatase 2A by the Viral Phosphoprotein,”J. Virol. 72(7):5610-5618 (1998).
Blaese et al., “Vectors in Cancer Therapy: How Will They Deliver?”Cancer Gene Therapy 2:291-297 (1995).
Blaese et al., “T Lymphocyte-Directed Gene Therapy for ADA- SCID: Initial Trial Results After 4 Years,”Science 270(5235):475-480 (1995).
Buchscachher et al., “Human Immunodeficiency Virus Vectors for Inducible Expression of Foreign Genes,”J Virol 66(5):2731-2739 (1992).
Carbonetti et al., “Use of Purtussis Toxin Vaccine Molecule PT9K/129G to Deliver Peptide Epitopes for Simulation of a Cytotoxic T Lymphocyte Response,”Abstr. Annu. Meet. Am. Soc. Microbiol. 95:295 (1995).
Chem et al., “The Regulator of MAT2 (ROM2) Protein Binds to Early Maturation Promoters and Represses PVALF-Activated Transcription,”Plant Cell 8(2):305-321 (1996).
Cho et al., “Analysis of the C-Terminal Region of Arabidopsis Thaliana Apetalai As a Transcription Activation Domain,”Plant Mol. Biol. 40(3):419-429 (1999).
Choo et al., “Toward a Code for the Interactions of Zinc Fingers With DNA: Selection of Randomized Fingers Displayed on Phage,”PNAS 91:11163-11167 (1994).
Choo et al., “Selection of DNA Binding Sites for Zinc Fingers Using Randomized DNAS Reveals Coded Interactions,”PNAS 91:11168-11172 (1994).
Cirillo et al., “Binding of the Winged-Helix Transcription Factor HNF3 to a Linker Histone Site on the Nucleosome,”EMBO J. 17:244-254 (1998).
Clarke-Curtiss & Curtiss, “Analysis of Recombinant DNA UsingEscherichia coliMinicells,”Methods in Enzymology 101:347-362 (1983).
Colley, et al., “Conversion of a Golgi Apparatus Sialyltransferase to a Secretory Protein by Replacement of the NH2-Terminal Signal Anchor With a Signal Peptide,”J. Biol. Chem. 264(30):17619-17622 (1989).
Collingwood, et al., “Nuclear Receptors: Coactivators, Corepressors and Chromatin Remodeling in the Control of Transcription,”J. Mol. Endocrinol. 23(3):255-275 (1999).
Conn, et al., “Amino Acid and cDNA Sequences of a Vascular Endothelial Cell Mitogen That is Homologous to Platelet-Derived Growth Factor,”PNAS US
Gregory Philip D.
Rebar Edward J.
Zhang H. Steve
Pasternak Dahna S.
Robins & Pasternak LLP
Sangamo Biosciences, Inc.
Wehbe Anne Marie S
LandOfFree
Anti-angiogenic methods and compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-angiogenic methods and compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-angiogenic methods and compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4232006